Bard Evaluates Tyco Announcement.Business Editors MURRAY HILL, N.J.--(BW HealthWire)--Jan. 23, 2002 C. R. Bard C. R. Bard, Inc. (NYSE: BCR) is one of the large S&P 500 companies of the United States, a surgical specialties and hospital medical device manufacturer in Murray Hill, New Jersey. It is named after its founder, who sold the company within only a few years of its founding. , Inc. (NYSE NYSE See: New York Stock Exchange : BCR BCR B Cell Receptor BCR Business Communications Review (magazine) BCR Banca Comerciala Romana (Romanian bank) BCR Breakpoint Cluster Region BCR Benefit/Cost Ratio BCR Bay City Rollers ) today announced that it is studying the announcement by Tyco International Ltd. of its plan to separate into four independent publicly traded companies. Bard's Chairman and Chief Executive Officer, William H. Longfield, said, "We are reviewing the impact of Tyco's announcement on our proposed merger, and we and Tyco are engaged in discussions. We will report back to our shareholders when we have more information." C. R. Bard, Inc., (www.crbard.com) headquartered in Murray Hill, New Jersey
|
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion